Freestone Grove Partners »

Arbutus Biopharma shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $81k 18k 4.50

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Axis Cap Hldgs SHS (AXS)
Datadog Cl A Com (DDOG)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
BP Sponsored Adr (BP)
Elastic N V Ord Shs (ESTC)
Pinnacle Finl Partners (PNFP)
Intuitive Surgical Com New (ISRG)
Dynatrace Com New (DT)
Xcel Energy (XEL)
Mondelez Intl Cl A (MDLZ)

View all positions for Freestone Grove Partners

Top funds holding Arbutus Biopharma

Morgan Stanley
Two Seas Capital
Whitefort Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Rubric Capital Management
State Street Corporation
Adage Capital Partners GP
Geode Capital Management
ADAR1 Capital Management
Legal & General Group
Woodline Partners
Leucadia National Corporation
BlackBarn Capital Partners

View all funds holding Arbutus Biopharma